Pioneering the next generation of mental health treatments
We are on a mission to develop effective, rapid-acting and accessible medicines for people living with mental health conditions
Self Reflected by Greg Dunn
Reducing
the unmet
need in
mental
health
Nearly 1 billion people suffer from mental disorders around the world.
World Health Organisation, 2022
The global economic cost of mental health disorders is expected to reach $6 trillion by 2030.
The Lancet Global Health · Mental health matters, 2020
Most people living with a mental disorder do not have access to effective care.
World Health Organisation, 2022

We want to be a part of the solution. 


Leveraging
the potential of
next-generation
compounds

Studies have shown that our investigational psychedelic-based compounds

can be administered in a short clinic visit
are well-tolerated
can deliver rapid, robust, and lasting treatment effects
Supporting
patients
and
trial
participants

We are proud to support initiatives in-house and across the mental health landscape to accelerate research into novel mental health treatments and enhance the patient experience.

More about
Patients
News
and
views
Read all news